•
Sep 30, 2022

Nkgen Biotech Q3 2022 Earnings Report

Total Revenue
$77K
EPS
-$1.1
Previous year: $0.03
-3766.7%
Gross Profit
$74K
Cash and Equivalents
$728K
Previous year: $1.89M
-61.6%
Free Cash Flow
-$641K
Total Assets
$174M
Previous year: $174M
-0.3%

Nkgen Biotech

Nkgen Biotech